drugset / Trial / NCT04617613
Comparing Different Regimens for Eradication of Helicobacter Pylori in Kuwait
RandomizedParallel-groupTriple-blindTreatment
Summary
Eradication of H. pylori reduces morbidity in patients with chronic gastritis and can prevent gastric cancer. We aimed to evaluate the efficacy of clarithromycin-based triple therapy and non-bismuth based quadruple therapy for eradicating H. pylori in patients with chronic gastritis in Kuwait.
Timeline
- Start
- 2016-09
- Primary completion
- 2018-09
- Completion
- 2019-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Metronidazole | Small molecule | 500 mg | — |
| Comparator | Amoxicillin | Other / unclassified | 1 g | — |
| Comparator | Clarithromycin | Small molecule | 500 mg | — |
| Comparator | Omeprazole | Other / unclassified | 20 mg | — |